Senzime AB (publ) Share Price Nasdaq Stockholm
Equities
SE0002478776
Medical Equipment, Supplies & Distribution
Sales 2024 * | 79.8M 7.38M 588M | Sales 2025 * | 198M 18.35M 1.46B | Capitalization | 879M 81.24M 6.47B |
---|---|---|---|---|---|
Net income 2024 * | -106M -9.8M -781M | Net income 2025 * | -34M -3.14M -251M | EV / Sales 2024 * | 10.5 x |
Net cash position 2024 * | 42M 3.88M 309M | Net cash position 2025 * | 5M 462K 36.84M | EV / Sales 2025 * | 4.4 x |
P/E ratio 2024 * |
-8.25
x | P/E ratio 2025 * |
-25.3
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 33.66% |
Latest transcript on Senzime AB (publ)
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 51 | 31/12/15 | |
Director of Finance/CFO | 54 | 31/12/21 | |
Fredrik Norrby
CTO | Chief Tech/Sci/R&D Officer | 48 | 31/12/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 51 | 31/12/15 | |
Director/Board Member | 71 | 31/12/22 | |
Jenny Freeman
BRD | Director/Board Member | 70 | 31/12/21 |
1st Jan change | Capi. | |
---|---|---|
-3.79% | 184B | |
-0.84% | 108B | |
-3.75% | 67.8B | |
+3.45% | 51.05B | |
+9.04% | 44.67B | |
+3.40% | 41.78B | |
+3.21% | 26.78B | |
+3.66% | 26.59B | |
+15.23% | 25.86B |